Equillium
clinically validated in severe dermatological disease | Equillium
Company
Deck Type
Sector
Industry
Deck date
December 2023
Slide
20 of 32
Similar slides by Equillium
See diffirences between slides (animation)
Investor Presentation
February 2024
clinically validated in severe dermatological disease | Equillium
Investor Presentation
November 2023
clinically validated in severe dermatological disease | Equillium
Investor Presentation
August 2023
clinically validated in severe dermatological disease | Equillium
Related slides by other companies
Oculis
Investor Presentation
July 2023
study overview | Oculis
Axcella Health
Results
September 2022
phase clinical trial underway interim analysis when subjects arm reached week | Axcella Health
ATAI
Investor Presentation
January 2024
core study weeks phase a is an open label in patients | ATAI
Ocuphire Pharma
Investor Presentation
August 2023
phase summary and next steps to have a clinically meaningful impact on preventing progression to reduce likelihood of vision loss in diabetic patients our goal me | Ocuphire Pharma
Other recent decks by Equillium
See all presentations (5 decks)
Investor Presentation
February 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Results
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights